PL139946B1 - Process for preparing novel derivatives of piperidinediones - Google Patents

Process for preparing novel derivatives of piperidinediones Download PDF

Info

Publication number
PL139946B1
PL139946B1 PL1983244462A PL24446283A PL139946B1 PL 139946 B1 PL139946 B1 PL 139946B1 PL 1983244462 A PL1983244462 A PL 1983244462A PL 24446283 A PL24446283 A PL 24446283A PL 139946 B1 PL139946 B1 PL 139946B1
Authority
PL
Poland
Prior art keywords
formula
pyridyl
mixture
product
ether
Prior art date
Application number
PL1983244462A
Other languages
English (en)
Polish (pl)
Other versions
PL244462A1 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL244462A1 publication Critical patent/PL244462A1/xx
Publication of PL139946B1 publication Critical patent/PL139946B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL1983244462A 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinediones PL139946B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (2)

Publication Number Publication Date
PL244462A1 PL244462A1 (en) 1985-02-13
PL139946B1 true PL139946B1 (en) 1987-03-31

Family

ID=9279000

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1983244462A PL139946B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinediones
PL1983249750A PL140021B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione
PL1983249749A PL140992B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1983249750A PL140021B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione
PL1983249749A PL140992B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione

Country Status (29)

Country Link
US (1) US4721710A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0110755B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59161377A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR900006721B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE22561T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU565519B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1221967A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS244681B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (3) DD229407A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3366623D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK511383A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8406070A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI79536C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2535721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78747B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU191494B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE56209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL70099A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA19948A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO159852C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ206177A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07582A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH20421A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (3) PL139946B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT77607B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG1989G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (3) SU1333237A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (3) YU221183A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA838065B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
CN103534258B (zh) 2011-05-17 2016-09-14 普林斯匹亚生物制药公司 酪氨酸激酶抑制剂
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
EP2710007B1 (en) 2011-05-17 2019-12-11 The Regents of The University of California Kinase inhibitors
JP6203848B2 (ja) 2012-09-10 2017-09-27 プリンシピア バイオファーマ インコーポレイテッド キナーゼ阻害剤としてのピラゾロピリミジン化合物
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
ES2841248T3 (es) 2014-02-21 2021-07-07 Principia Biopharma Inc Sales y forma sólida de un inhibidor de BTK
CA2970723C (en) 2014-12-18 2023-09-05 Principia Biopharma Inc. Treatment of pemphigus
EP3313839A1 (en) 2015-06-24 2018-05-02 Principia Biopharma Inc. Tyrosine kinase inhibitors
AU2017290354C1 (en) 2016-06-29 2023-07-06 Principia Biopharma Inc. Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
JP2022550919A (ja) 2019-10-14 2022-12-05 プリンシピア バイオファーマ インコーポレイテッド (r)-2-[3-[4-アミノ-3-(2-フルオロ-4-フェノキシ-フェニル)ピラゾロ[3,4-d]ピリミジン-1-イル]ピペリジン-1-カルボニル]-4-メチル-4-[4-(オキセタン-3-イル)ピペラジン-1-イル]ペンタ-2-エンニトリルを投与することにより免疫性血小板減少症を治療する方法
EP4093741A1 (en) 2020-01-22 2022-11-30 Principia Biopharma Inc. Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
CS244681B2 (en) 1986-08-14
PL249749A1 (en) 1985-03-12
ATE22561T1 (de) 1986-10-15
IL70099A (en) 1987-10-20
PH20421A (en) 1987-01-05
CA1221967A (en) 1987-05-19
IE56209B1 (en) 1991-05-22
DK511383D0 (da) 1983-11-08
OA07582A (fr) 1985-03-31
JPS59161377A (ja) 1984-09-12
NO159852B (no) 1988-11-07
EP0110755A1 (fr) 1984-06-13
FI79536C (fi) 1990-01-10
FI834087A0 (fi) 1983-11-08
PL140992B1 (en) 1987-06-30
DD219770A5 (de) 1985-03-13
FR2535721A1 (fr) 1984-05-11
HU191494B (en) 1987-02-27
PT77607A (fr) 1983-12-01
US4721710A (en) 1988-01-26
PT77607B (fr) 1986-03-18
FR2535721B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-05-17
SG1989G (en) 1989-06-02
GR78747B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-02
ES527091A0 (es) 1984-07-01
AU2089883A (en) 1984-05-17
DE3366623D1 (en) 1986-11-06
YU184285A (en) 1986-06-30
PL244462A1 (en) 1985-02-13
AU565519B2 (en) 1987-09-17
DK511383A (da) 1984-05-09
NZ206177A (en) 1985-11-08
IE832581L (en) 1984-05-08
YU221183A (en) 1986-06-30
NO834057L (no) 1984-05-09
EP0110755B1 (fr) 1986-10-01
IL70099A0 (en) 1984-01-31
YU184185A (en) 1986-06-30
FI79536B (fi) 1989-09-29
SU1333237A3 (ru) 1987-08-23
KR900006721B1 (ko) 1990-09-20
KR840006641A (ko) 1984-12-01
DD229402A5 (de) 1985-11-06
SU1333238A3 (ru) 1987-08-23
MA19948A1 (fr) 1984-07-01
SU1316558A3 (ru) 1987-06-07
NO159852C (no) 1989-02-15
PL249750A1 (en) 1985-03-12
ZA838065B (en) 1984-06-27
ES8406070A1 (es) 1984-07-01
DD229407A5 (de) 1985-11-06
FI834087L (fi) 1984-05-09
PL140021B1 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
PL139946B1 (en) Process for preparing novel derivatives of piperidinediones
DE69205327T2 (de) Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente.
US4613603A (en) Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in which they are present
DD283395A5 (de) Verfahren zur herstellung von tetrahydropyridinen
PL137200B1 (en) Method of obtaining derrivatives of pyridazine
US4940789A (en) 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
CA1185604A (en) Phenethanolamine derivatives
PL117572B1 (en) Process for preparing novel derivatives of trans-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindine3,4,4a,5,6,7,7a-oktagidro-1h-2-piridina
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
US3426017A (en) Sulfonylurea compounds
JPS60204762A (ja) 製薬学的に活性なピペリジン誘導体及びその使用
FI79538B (fi) Foerfarande foer framstaellning av hjaertmuskeln skyddande -butyrolaktonderivat med rytmstoerningar avlaegsnande verkan.
JPH0115501B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS59184162A (ja) キノリン誘導体、その製造法及び該化合物を含有する、5―ヒドロキシトリプタミン桔抗質として使用する医薬組成物
JPS5810387B2 (ja) 4,5,6,7テトラヒドロイミダゾ〔4,5−c〕ピリジン誘導体及びその製法
US5508401A (en) Substituted dibenzo[a,d]cycloheptene NMDA antagonists
EP0347733A1 (en) Optically active hydantoin derivatives
JP2638189B2 (ja) カルボン酸イミド又はその酸付加塩及び抗不整脈剤
JPH0616557A (ja) 脳機能障害改善剤
US4010161A (en) Piperazinoethyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3Δ-pyrazolin-4-yl)carbamates
JPS6125030B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6017789B2 (ja) 5−(ω−アミノアシル)−3−カルボアルコキシアミノ−10,11−ジヒドロ−5H−ジベンゾ−〔b,f〕−アゼピン、その塩及びそれらの製造方法
CS244695B2 (cs) Způsob přípravy derivátů 2,6-piperidíndionu
WO2002053157A1 (en) Thiazolidine derivative
JPS5910566A (ja) ヒドロキシイミノおよびアルコキシイミノ誘導体、その製造法およびそれを有効成分とするカルシウム「きつ」抗剤